MedTrace Logo

Edwards EVOQUE Eos MISCEND Study

NCT02718001 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 123

Last updated 2026-04-13

No results posted yet for this study

Summary

Study to evaluate the safety and performance of the Edwards EVOQUE Eos mitral valve replacement system

Conditions

  • Mitral Valve Regurgitation (Degenerative or Functional)

Interventions

DEVICE

Edwards EVOQUE Eos Mitral Valve Replacement System

Replacement of the mitral valve through a transcatheter approach

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Rajendra Makkar, MD · Cedars-Sinai Medical Center, Los Angeles, CA

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-06
Primary Completion
2028-04-30
Completion
2033-04-30
FDA Device
Yes

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02718001 on ClinicalTrials.gov